Concentrations |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Risks and Uncertainties [Abstract] | |
| Concentrations | Note 7 – Concentrations The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of its cash and accounts receivable. The Company maintains its cash balances in bank deposit and money market accounts which, at times, may exceed federally insured limits. Sales and Accounts Receivable
During the periods ended March 31, 2026 one (1) customer totaled 43% of accounts receivable. In the period ended March 31, 2025 three (3) customers totaled 82% of accounts receivable.
The Company performs ongoing credit valuations on its customers and management believes that the financial viability of these customers its sound. Purchases and Payables There was no concentration of purchases or payables for the Company for the three months ended March 31, 2026, and the year ended December 31, 2025. |